Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer

NCT00274859 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group